PSMA Antikörper

Patent europeic · EP2360169 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2360169
Numer da la dumonda
EP10184957
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
23-10-2002
Publitgà
24-08-2011
Concedì
14-10-2015
Stritgà
14-10-2015
Motiv
Revocà en la procedura d’opposiziun
Classas IPC
C07H 21/04 (2006.01)
C12N 5/12 (2006.01)
C07K 16/00 (2006.01)
A61K 39/395 (2006.01)
G01N 33/53 (2006.01)
Prioritad
US 335215 P 23.10.2001
US 362747 P 07.03.2002
US 412618 P 20.09.2002
Derivà da
EP02802198
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 25-06-2024

    Midada

    Published in Swissreg on 25.06.2024

  2. 15-06-2018

    Midada

    Published in Swissreg on 15.06.2018

  3. 14-10-2015

    Concedì

    Published in Swissreg on 14.10.2015

Partidas

Possessur

Psma Development Company, L.L.C.

Progenics Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, New York 10591, US

Inventur

Maddon, Paul

Scarsdale NY New York 10583, US

Donovan, Gerald

New York NY New York 10021, US

Olson, William

Ossining NY New York 10562, US

Schulke, Norbert

New City NY New York 10956, US

Gardner, Jason

Ardsley NY New York 10502, US

Ma, Dangshe

Millwood NY New York 10546, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.